Seidel C, Børset M, Hjorth-Hansen H, Sundan A, Waage A
Institute of Cancer Research and Molecular Biology, Norwegian University of Science, Trondheim, Norway.
Med Oncol. 1998 Sep;15(3):145-53. doi: 10.1007/BF02821933.
Multiple myeloma is characterised by the clonal expansion of malignant plasma cells. Recently, we reported that a new cytokine, hepatocyte growth factor (HGF), and its receptor c-met are related to this disease. Here we review the observations that associate HGF with myeloma. Malignant plasma cells produce HGF and express the receptor c-met. Many patients have elevated HGF levels, which is unfavourable both in terms of survival and response to treatment. Possible biological roles of HGF in this disease are discussed, with special focus on bone homeostasis and its binding to heparan sulphate proteoglycans.
多发性骨髓瘤的特征是恶性浆细胞的克隆性增殖。最近,我们报道了一种新的细胞因子——肝细胞生长因子(HGF)及其受体c-met与该疾病有关。在此,我们综述了将HGF与骨髓瘤相关联的观察结果。恶性浆细胞产生HGF并表达受体c-met。许多患者的HGF水平升高,这在生存和对治疗的反应方面都是不利的。本文讨论了HGF在该疾病中可能的生物学作用,特别关注骨稳态及其与硫酸乙酰肝素蛋白聚糖的结合。